top biopharmaceuticals for glp-1 medication 2025’s Breakthrough Obesity Treatments: Companies & Innovations 20 Companies in Glucagon-Like Peptide-1

Semaglutide is available in three formulations: the injectable Ozempic, Wegovy, and the oral tablet Rybelsus

Behind the scenes the market leans on active pharmaceutical ingredients, peptide synthesis technologies, biologic manufacturing processes, and better drug delivery systems that keep the effect stable

These appetite-suppressing treatments can help you manage hunger, support metabolic health, and make lasting progress

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the First-in-Class GLP-1 and Amylin Receptor Agonist, Amycretin: A First-in-Human, Phase 1, Double-Blind, Randomised, Placebo-Controlled Trial

Opdivo's patent is set to expire in 2028, but the exploration of immunotherapy and combination therapies continues